Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Vickerman

Showing results (291-300 of 397) with videos related to

Pageof 40
Sort By:
Trials|July 31, 2016
Hepatitis C - Assessment to Treatment Trial (HepCATT) in primary care: study protocol for a cluster randomised controlled trialKirsty Roberts, John Macleod, Chris Metcalfe, et al.
AIDS (London, England)|January 26, 2026
Modelling the impact of underage and coerced entry into sex work on HIV transmission in Tijuana, MexicoHannah Fraser, Jack Stone, Adam Zienkiewicz, et al.
Addiction (Abingdon, England)|May 28, 2011
The impact of needle and syringe provision and opiate substitution therapy on the incidence of hepatitis C virus in injecting drug users: pooling of UK evidenceKaty M E Turner, Sharon Hutchinson, Peter Vickerman, et al.
Addiction (Abingdon, England)|July 16, 2019
Cost-effectiveness of scaling-up HCV prevention and treatment in the United States for people who inject drugsCarolina Barbosa, Hannah Fraser, Thomas J Hoerger, et al.
BMC Infectious Diseases|November 10, 2019
Integrated treatment of hepatitis C virus infection among people who inject drugs: study protocol for a randomised controlled trial (INTRO-HCV)Lars T Fadnes, Christer Frode Aas, Jørn Henrik Vold, et al.
Plos Medicine|June 1, 2021
Integrated treatment of hepatitis C virus infection among people who inject drugs: A multicenter randomized controlled trial (INTRO-HCV)Lars T Fadnes, Christer Frode Aas, Jørn Henrik Vold, et al.
Open Forum Infectious Diseases|February 12, 2024
Scale-up of Direct-Acting Antiviral Treatment in Prisons Is Both Cost-effective and Key to Hepatitis C Virus EliminationSophy T F Shih, Jack Stone, Natasha K Martin, et al.
Addiction (Abingdon, England)|November 3, 2020
Association between opioid agonist therapy use and HIV testing uptake among people who have recently injected drugs: a systematic review and meta-analysisClaire F Ferraro, Daniel E Stewart, Jason Grebely, et al.
The Lancet. Global Health|August 9, 2014
Assessment of the population-level effectiveness of the Avahan HIV-prevention programme in South India: a preplanned, causal-pathway-based modelling analysisMichael Pickles, Marie-Claude Boily, Peter Vickerman, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 28, 2022
Prison-based interventions are key to achieving HCV elimination among people who inject drugs in New South Wales, Australia: A modelling studyJack Stone, Aaron G Lim, Gregory J Dore, et al.
Pageof 40

Showing results (291-300 of 397) with videos related to

Sort By:
Pageof 40
Trials|July 31, 2016
Hepatitis C - Assessment to Treatment Trial (HepCATT) in primary care: study protocol for a cluster randomised controlled trialKirsty Roberts, John Macleod, Chris Metcalfe, et al.
AIDS (London, England)|January 26, 2026
Modelling the impact of underage and coerced entry into sex work on HIV transmission in Tijuana, MexicoHannah Fraser, Jack Stone, Adam Zienkiewicz, et al.
Addiction (Abingdon, England)|May 28, 2011
The impact of needle and syringe provision and opiate substitution therapy on the incidence of hepatitis C virus in injecting drug users: pooling of UK evidenceKaty M E Turner, Sharon Hutchinson, Peter Vickerman, et al.
Addiction (Abingdon, England)|July 16, 2019
Cost-effectiveness of scaling-up HCV prevention and treatment in the United States for people who inject drugsCarolina Barbosa, Hannah Fraser, Thomas J Hoerger, et al.
BMC Infectious Diseases|November 10, 2019
Integrated treatment of hepatitis C virus infection among people who inject drugs: study protocol for a randomised controlled trial (INTRO-HCV)Lars T Fadnes, Christer Frode Aas, Jørn Henrik Vold, et al.
Plos Medicine|June 1, 2021
Integrated treatment of hepatitis C virus infection among people who inject drugs: A multicenter randomized controlled trial (INTRO-HCV)Lars T Fadnes, Christer Frode Aas, Jørn Henrik Vold, et al.
Open Forum Infectious Diseases|February 12, 2024
Scale-up of Direct-Acting Antiviral Treatment in Prisons Is Both Cost-effective and Key to Hepatitis C Virus EliminationSophy T F Shih, Jack Stone, Natasha K Martin, et al.
Addiction (Abingdon, England)|November 3, 2020
Association between opioid agonist therapy use and HIV testing uptake among people who have recently injected drugs: a systematic review and meta-analysisClaire F Ferraro, Daniel E Stewart, Jason Grebely, et al.
The Lancet. Global Health|August 9, 2014
Assessment of the population-level effectiveness of the Avahan HIV-prevention programme in South India: a preplanned, causal-pathway-based modelling analysisMichael Pickles, Marie-Claude Boily, Peter Vickerman, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 28, 2022
Prison-based interventions are key to achieving HCV elimination among people who inject drugs in New South Wales, Australia: A modelling studyJack Stone, Aaron G Lim, Gregory J Dore, et al.
Pageof 40